Welcome to MCDC's Newest Members

DynPort Vaccine, Biologics Modular, The Conafay Group, & Oryn Therapeutics LLC.

View Current Members >>


Prophylaxis, pretreatment, and post-exposure prophylaxis


Systems and devices to identify CBRN agents and assist in making medical decisions


Therapeutics for post-exposure and post-symptomatic

NOTICE: Name Change

The National Chemical & Biological Defense Consortium is now the Medical CBRN Defense Consortium (MCDC). While we feel the new name and logo better reflect the technology areas specific to the medical countermeasures Other Transaction Agreement, nothing else about the consortium is changing. Over the next few months you will be able to connect with us using either the new email addresses and website URL or the old.

Event: Proposers Conference

A remote Proposers Conference has been scheduled for Thursday, July 7th from 2:00 to 3:00 pm EDT. This call will focus on full proposal requirements for the MCDC-RPP-16-01 Request for Prototypes Proposals

Learn More
Government Intent to Announce Proposals for MCDC OTA

Today the U.S. Army Contracting Command, Picatinny Arsenal, New Jersey, on behalf of the Joint Project Manager for Medical Countermeasure Systems (JPM-MCS) through the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), announced via FBO (W15QKN-16-Z-05SM) its intent to announce Requests for Prototype Proposals (RPPs) under the OTA with the MCDC. This is an intent to announce for planning purposes only and not an actual solicitation.

read more